Moody’s assigns rating to INTEGRIS Health’s bonds

Moody’s Investors Service has assigned an “Aa3” rating to $194 million of Oklahoma City-based INTEGRIS Health Obligated Group’s proposed series 2015 A fixed rate bonds and an “Aa3/P-1” rating to $48 million of series 2015B multi-mode variable rate bonds.

Advertisement

The “Aa3” long-term rating was supported by a number of factors, including INTEGRIS’ solid market position and strong management and governance.

The system also faces some challenges, which were considered for the rating assignment, such as operating in a highly competitive healthcare market and the system’s planned use of cash for increased capital spending.

INTEGRIS has a stable outlook, which is based on Moody’s expectation that the system will continue to have positive margins. Moody’s also expects the system to have “careful oversight of multiple major capital projects over the next few years.”

More articles on healthcare finance:

Geisinger admissions rise, net income falls
Moody’s to join EMMA later this year
CMS launches network to facilitate Medicare payment overhaul

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.